Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1052 (LINC01052) is a human long non-coding RNA gene. It does not encode a protein but is transcribed as a long RNA molecule that does not overlap with known protein-coding genes. LINC01052 fits into the broad subclass of long intergenic non-coding RNAs (lincRNAs), which are autonomously transcribed and play regulatory roles in various cellular processes, such as modulating chromatin state, regulating neighboring gene expression, or acting as scaffolds for ribonucleoprotein complexes. However, its specific biological function, tissue expression, disease associations, and molecular partners remain largely uncharacterized and are not referenced in any of the major biological, genomic, or drug-focused databases currently.
Not applicable; there are no drugs reported to target this molecule, and the biological mechanism is not yet characterized beyond general lncRNA functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1052 (LINC01052).